Quadrant Capital Group’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$340K Buy
88,267
+87,696
+15,358% +$320K 0.01% 1045
2026
Q1
$2.26K Buy
+571
New +$2.88K ﹤0.01% 2489
2023
Q1
Sell
-279
Closed -$776 2761
2022
Q4
$776 Buy
+279
New +$834 ﹤0.01% 2580
2018
Q2
Sell
-198
Closed 2182
2018
Q1
$0 Buy
+198
New +$2.31K ﹤0.01% 2190
2016
Q2
Sell
-673
Closed -$5K 2032
2016
Q1
$5K Buy
+673
New +$5.59K ﹤0.01% 1164

Other funds holding MDXG

Quadrant Capital Group's MDXG Position: Q2 2026 in Review

Quadrant Capital Group increased its MiMedx Group (MDXG) stake by 15,358% in Q2 2026, buying an estimated $320K and bringing the position to 88,267 shares worth $340K. The position accounts for 0.01% of the portfolio, ranked #1045.

Quadrant Capital Group first reported a position in MDXG in Q1 2016 and has held it in 5 quarters since. 227 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

  • Quadrant Capital Group held 88,267 shares of MiMedx Group worth $340K as of Q2 2026.
  • Quadrant Capital Group bought 87,696 MiMedx Group shares in Q2 2026, an estimated $320K.
  • MiMedx Group made up 0.01% of Quadrant Capital Group's portfolio in Q2 2026, its #1045 holding.
  • Quadrant Capital Group first reported a position in MiMedx Group in Q1 2016 and has held it in 5 quarters since.
  • 227 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.